Cancer Surgery

Make sense of your choices, understand the proposed operation, and prepare for recovery—with clear explanations to help you talk with your cancer team.

Surgical team using robotic instruments in an operating theatre
On this pageStart hereWill surgery help me?Treatment before and after surgeryUnderstanding my operationFunction, appearance and reconstructionOpen, keyhole or robotic surgeryGetting readyConsent and the day of surgeryRecovery in hospitalRecovery at homeWhen to seek urgent helpResults and next stepsQuestions, costs and practical plansSurgery in particular situationsCommon questionsNames of operationsRelated readingSources and further reading

Start here: your surgery plan

If surgery has been suggested, start with what it could do for you. You do not need to learn every surgical term before talking with your team.

  • Understand the aim and alternatives. Ask what the operation is expected to achieve for you, how it compares with other choices and what it may mean for daily life.
  • Ask how treatments fit together. Medicines or radiotherapy may be needed before or after surgery. Ask what the whole plan involves.
  • Prepare for recovery. Discuss eating, movement, medicines and help at home. Ask for written instructions and a contact number.
  • Know when to seek help. If you have already had surgery and feel unwell, follow your surgical team’s urgent-care instructions. Do not wait for a routine appointment or a WhatsApp reply.

You can bring someone you trust and read the sections you need, one at a time.

Cancer surgery can help diagnose cancer, remove it, assess its spread or relieve a problem it is causing. Surgical oncology is the specialty concerned with cancer operations. Your surgical oncologist or organ-specific cancer surgeon works with other specialists to plan care around your diagnosis, health and priorities.

Will surgery help me—and what are my alternatives?

The first decision is whether an operation offers a worthwhile benefit for you. Its name, size or technology comes later. The team considers the type and extent of cancer, its biology—features that affect how it behaves and responds to treatment—your health, and what matters most to you.

Be clear about the goal

For many solid tumours, surgery is an important part of treatment and may be the main treatment. Surgery with curative intent aims to remove the cancer completely; “intent” describes the goal, rather than a guarantee of cure. Surgery treats the area being operated on. Medicines or radiotherapy may be needed alongside it to address other risks.

An operation may instead aim to establish a diagnosis, assess spread or relieve symptoms. Palliative surgery focuses on relief or function, while risk-reducing or prophylactic surgery addresses a high risk of a future cancer. These goals need different discussions. Surgery is usually not the main treatment for blood cancers such as leukaemia, lymphoma or myeloma, although a biopsy or treatment of a particular complication may be needed.

Bring the findings and your priorities together

A multidisciplinary team (MDT), also called a tumour board, brings together specialists such as surgical, medical and radiation oncologists, radiologists and pathologists. Reconstructive surgeons and other specialists join when needed. They review the findings and recommend options; your treating team discusses those options with you.

Tell the team about the activities and responsibilities you want to protect: eating, speaking, walking, working, caring for someone, sexual function or having children. Your concerns about appearance, dependence on others or the length of recovery also belong in this conversation.

Resectability, fitness and benefit are separate questions

Resectable means the cancer is considered removable with the intended operation. Operable often refers to whether a person can undergo surgery with an acceptable balance of benefit and risk, although clinicians sometimes use these words differently. Ask about both the technical possibility of removal and your fitness for the proposed operation.

Being able to remove a tumour does not establish that removal will help

Technical resectability does not, by itself, mean surgery is required or will improve outcomes. Even if a tumour can be removed and you are fit enough for surgery, the team must explain whether the operation is likely to help you live longer, reduce the chance of cancer returning (recurrence), relieve symptoms or preserve useful function compared with the alternatives.

For example, removing one tumour may not control cancer that is active in many places. Some cancers can be treated effectively with medicines, radiotherapy or a selected organ-preservation approach. For some low-risk cancers, active surveillance—regular checks, with treatment considered if the disease changes—can avoid or postpone treatment-related harm.

The operation's risks, effects on function and recovery burden must be weighed against its expected clinical benefit. Surgery may also delay another treatment. A decision against surgery can be a considered cancer-treatment decision, with an alternative care plan.

Borderline resectable means surgery is uncertain or particularly challenging under cancer-specific criteria, for example because of nearby blood vessels. Technically unresectable means the intended removal cannot currently be achieved. Treatment sometimes makes removal possible later, called conversion treatment followed by conversion surgery. This requires reassessment; an operation cannot be promised.

Understand the alternatives and the time available

Depending on the cancer, alternatives may include drug treatment, radiotherapy, a procedure through a scope, surveillance, symptom-directed care or a clinical trial. Ask what each option is expected to achieve, what it would involve, and what is likely to happen without the proposed operation.

A second opinion can help when an operation would remove an organ, have major effects on function, or when there are several reasonable options. Ask how much time is available to decide. An emergency blockage, major bleeding or another urgent problem may leave less time for discussion.

Why might I need a biopsy or diagnostic laparoscopy first?

Sometimes the next step is to get information before committing to a larger operation. Diagnostic surgery obtains tissue to establish a diagnosis; staging surgery helps assess the extent of cancer and choose treatment.

Understanding what a biopsy can tell us

A biopsy takes tissue for examination by a pathologist, the specialist who diagnoses disease in tissue and cells. A core needle biopsy takes small tissue cylinders through a needle. An incisional biopsy removes part of an abnormal area; an excisional biopsy removes the whole abnormal area. A needle or endoscopic biopsy can often provide the diagnosis without a larger operation.

Removing a lump for diagnosis is not always the same as completing the cancer operation. Further surgery may be needed to achieve appropriate margins—the edges of the removed tissue—or to assess nearby lymph nodes. For suspected bone or soft-tissue sarcoma, biopsy planning should involve the specialist team because the route of the biopsy can affect later surgery.

What does diagnostic laparoscopy (D-LAP) mean?

Diagnostic laparoscopy, sometimes written informally as “D-lap”, uses a camera through small abdominal cuts to inspect the abdomen. When its purpose is to assess cancer extent, it is also called staging laparoscopy. It can reveal small deposits on the abdominal lining, called the peritoneum, that scans have not shown. The surgeon may take biopsies, fluid samples or washings.

Peritoneal washings involve putting sterile fluid into the abdomen and collecting it for a laboratory to look for cancer cells. This is a sampling test, rather than a treatment that washes cancer away. Clear findings cannot exclude every microscopic deposit.

A staging laparoscopy may be a separate procedure or the first part of a planned operation. Ask beforehand what will happen if it shows that the main operation would not help. The team may stop after sampling and recommend another treatment instead of continuing with a major resection.

Once the diagnosis and extent are sufficiently clear, the next question is how surgery fits with the rest of treatment.

Why treatment may come before or after surgery

It can be unsettling to hear that you need treatment before an operation, or more treatment after the cancer has been removed. These treatments can have different, complementary jobs. The sequence is part of the cancer treatment plan.

Surgery deals with the area being operated on, but some cancers can release microscopic cells elsewhere before an operation. These cells may be too small for scans to detect. Medicines that act throughout the body, called systemic therapy, can address that risk. Radiotherapy treats a planned local area. Each treatment has a different role.

Before surgery: neoadjuvant therapy

Neoadjuvant therapy is treatment given before the main operation. Depending on the cancer, it may use chemotherapy, immunotherapy, targeted therapy, hormonal or endocrine therapy, radiotherapy, or a selected combination. Chemoradiotherapy combines chemotherapy with radiation. These approaches are not interchangeable and are not all useful for every diagnosis.

When supported by evidence for the particular cancer, treatment before surgery may:

  • Treat microscopic disease early: systemic treatment reaches beyond the main tumour, including possible cells elsewhere that scans cannot show.
  • Shrink or downstage a tumour: reduce its size or extent and sometimes improve the chance of an appropriate complete removal.
  • Support organ preservation: in selected situations, make breast conservation or another less extensive local treatment feasible.
  • Show how the cancer responds: the response on scans and in the removed tissue can help guide later decisions in cancers where evidence supports doing so.
  • Improve longer-term outcomes: in particular cancer settings, a proven treatment strategy can reduce recurrence and may improve survival compared with the relevant alternative.

Neoadjuvant treatment can therefore be appropriate even when the cancer is already technically resectable. It is not merely a way to make an “inoperable” cancer removable. For example, some breast-cancer pathways use response to preoperative treatment to guide postoperative therapy; some stomach, oesophageal, rectal and lung cancer pathways use treatment before surgery as part of an evidence-based overall plan. The exact recommendation depends on the subtype, stage and relevant test results.

Giving the same treatment earlier is not automatically better in every cancer. Some people benefit mainly from tumour shrinkage or preservation of an organ; others have evidence for improved recurrence or survival outcomes with a particular combined strategy. Ask which benefit is expected in your situation and which comparison supports it.

How is surgery planned after neoadjuvant treatment?

The team plans the course, monitors symptoms and side effects, and reassesses the cancer and your fitness. Repeat scans or other tests help determine the next step. Surgery is scheduled with attention to treatment response and recovery from side effects.

Treatment can cause significant side effects, and some cancers do not respond or can progress. The plan may need to change. A tumour disappearing on a scan does not by itself prove that all cancer has gone or mean surgery can be omitted. Any non-operative or “watch-and-wait” option requires cancer-specific selection, an informed discussion and a structured surveillance plan.

After surgery: adjuvant therapy

Adjuvant therapy is additional treatment after the main operation, intended to lower the chance of cancer returning. It may involve chemotherapy, endocrine therapy, immunotherapy, targeted treatment or radiotherapy when supported for that cancer. It is often recommended after a complete operation with clear margins, rather than only when visible tumour remains.

Adjuvant systemic treatment targets possible microscopic cells elsewhere. Adjuvant radiotherapy treats a defined area to reduce the risk of recurrence there. In the right cancer and risk group, these approaches can reduce recurrence and some also improve survival. They lower risk; they cannot guarantee that recurrence will never happen.

The decision uses the full pathology, including stage, nodes, margins and other cancer-specific risk features; treatment already given; and your recovery and health. Biomarkers, meaning measurable features of the cancer, or a validated genomic test can guide treatment in selected settings. Not everyone needs such testing or additional treatment.

For a closer look at this decision, read why chemotherapy may be recommended after surgery.

How do we know whether the additional treatment is worthwhile?

Ask about your estimated risk with surgery alone or the treatment already received, how much the proposed treatment is expected to reduce it, and the likely short- and long-term side effects. A reduction in risk can be worthwhile for one person and too small to justify toxicity for another. Some people can safely avoid unnecessary treatment after the team considers the evidence and their priorities.

Ask for the absolute benefit where a reliable estimate is available: how many fewer people out of 100 with a similar diagnosis would be expected to have a recurrence or die from the cancer over a stated period. Group estimates cannot predict an individual outcome. The duration, monitoring and timing should be explained; do not start, stop or delay treatment on your own.

Understanding the whole treatment sequence

Perioperative treatment means treatment around an operation, often including both before and after it. “Perioperative care” can also describe care throughout the surgical journey. Total neoadjuvant therapy (TNT), used in selected rectal cancer pathways, places the planned chemotherapy and radiotherapy components before surgery. It is a specific strategy, rather than a recommendation for every cancer.

Interval surgery is performed at a planned point after initial treatment, such as interval cytoreductive surgery in selected ovarian cancer pathways. Salvage surgery may be considered for selected cancer that persists or returns after earlier treatment; previous surgery or radiotherapy can make it more complex. “Limb salvage” is a different term referring to preservation of an arm or leg.

Ask the team to put your sequence into a simple written plan: the first treatment, when it will be reassessed, the proposed operation, and what will determine any treatment afterwards. Some decisions can be made now; others will depend on response and the final laboratory report.

Understanding the operation being proposed

Once surgery is recommended, ask your surgeon to describe or draw the planned operation: what will be removed, what can remain, whether lymph nodes need assessment, and how the area will be repaired. These details explain the operation more usefully than its name alone.

How much tissue needs to be removed?

Resection means removing tissue or part or all of an organ. Local excision removes an abnormal area with surrounding tissue; a wide local excision includes a planned surrounding margin. Partial resection removes part of an organ, such as part of a kidney, while total resection removes the whole named organ or structure. “Total” describes that removal; it does not promise that all cancer in the body has gone.

Radical surgery removes the cancer-bearing organ or tissue with associated surrounding structures, sometimes including regional lymph nodes, as defined for that operation. It does not mean every nearby organ must be removed. En bloc resection removes the tumour and involved adjoining tissue together in one piece. An extended or multivisceral resection includes parts of more than one organ when needed and justified.

The aim is the appropriate cancer operation while protecting useful tissue and function wherever possible. A more radical operation does not automatically improve the outcome. A smaller operation may be enough in one situation and inadequate in another; your team should explain the evidence for the recommended extent.

Why does the surgeon remove a margin around the cancer?

A surgical margin is the edge of the tissue removed. The pathologist examines the specimen to assess whether cancer reaches an edge. It is not the same as the visible scar on your skin.

  • Negative, clear or uninvolved margin: cancer is not seen at the examined edge.
  • Positive or involved margin: cancer reaches an edge under the definition used for that cancer and operation.
  • Close margin: cancer is near the edge. There is no single distance that is adequate for every cancer.

The position of a margin matters. Reports may mention a deep, radial or circumferential margin, meaning a particular surface around the specimen. The team interprets the result alongside the type of cancer, operation and any treatment already given.

Ask what margin is appropriate for your cancer and how the team balances clearance with preserving function. The final report helps determine whether any further treatment is needed; a close or involved margin does not automatically mean another operation.

Why might lymph nodes be checked or removed?

Lymph nodes are small structures in the immune and lymphatic systems. They help drain fluid from tissues. Cancer can spread to regional, or nearby, lymph nodes; checking them can help determine stage and guide later treatment.

What is a sentinel lymph-node biopsy?

The sentinel lymph nodes are the first nodes draining the tumour area; there can be more than one. Sentinel lymph-node biopsy (SLNB) identifies and removes these nodes for laboratory examination in selected cancers. Mapping may use a tracer, blue dye or a method chosen for the particular procedure.

A negative result means no cancer was found in the sentinel nodes examined. It may allow a person to avoid a larger node operation, but false-negative results can occur. A positive result helps guide the next decision; it does not automatically mean every remaining node must be removed or that the cancer is stage IV.

Sampling, dissection and lymphadenectomy

Lymph-node sampling removes selected nodes for assessment. Lymph-node dissection, also called lymphadenectomy, nodal resection or nodal clearance, removes a defined group. Examples include axillary dissection in the armpit, neck dissection, pelvic lymphadenectomy and groin-node dissection. The groups and extent depend on the cancer and previous treatment.

Some reports use D1 or D2 lymphadenectomy, particularly in stomach cancer. These describe cancer-specific groups of nodes removed, rather than the number of nodes or the stage. A completion dissection removes further nodes after an earlier assessment when indicated.

More extensive node removal is not always more beneficial. Ask what information or cancer-control benefit is expected, and whether a smaller operation, radiotherapy or observation is appropriate in your situation.

Lymphoedema and other effects

Lymphoedema is swelling caused by impaired lymph drainage. It may develop after node surgery or radiotherapy. Risk is generally lower after sentinel-node biopsy than a wider dissection, but is not zero. Numbness, restricted movement, fluid collections and, after some operations, nerve injury are other possible effects.

Ask about movement advice, skin care, rehabilitation and symptoms to report. New or increasing swelling needs assessment; sudden painful swelling may have another cause, including a blood clot.

If your report mentions involved nodes, our guide explains what cancer in the lymph nodes can mean.

Can a frozen section guide decisions during the operation?

A frozen section is a rapid laboratory examination performed while an operation is in progress. A pathologist freezes a small sample, prepares thin sections and examines it to answer a specific question. For example, it may help clarify whether a sample contains cancer or whether a selected margin needs more tissue removed.

It is useful in some situations and unsuitable or unnecessary in others. Sampling is limited, frozen tissue has less detail than the final prepared sections, and some diagnoses need additional tests. The pathologist may defer a decision until the final report.

A reassuring frozen-section result cannot replace the full permanent-section histopathology report, which examines tissue more thoroughly after processing. The final result can differ or provide important extra information.

Before you consent, ask which findings could change the plan during surgery and which decisions will wait for the final report. You should also have a chance to discuss what those changes could mean for daily life.

Protecting everyday function, appearance and independence

Living after treatment matters as well as getting through the operation. You can ask about eating, speech, movement, bowel and bladder control, sexual function, fertility and appearance before surgery is agreed. These concerns can affect the choice of operation, reconstruction and rehabilitation.

Can an organ or its function be preserved?

Organ-preserving or organ-sparing surgery aims to treat the cancer while retaining an organ or part of it when appropriate for cancer control. Function-preserving surgery focuses on how well the body will work afterwards. Keeping an organ does not always mean its function will be normal.

Examples include breast conservation, which removes the cancer while retaining most of the breast, commonly with radiotherapy; and nephron-sparing surgery, which preserves kidney tissue by removing only part of the kidney. Limb-sparing or limb-salvage surgery retains an arm or leg, often with reconstruction. Safe clearance, nerves, blood vessels and useful function all matter; sometimes amputation offers the safest or most useful outcome.

Sphincter-preserving surgery aims to retain the muscles controlling the anal opening, although bowel frequency, urgency or leakage may still change after rectal treatment. Nerve-sparing surgery aims to protect particular nerves when cancer clearance allows; after prostate surgery, it cannot guarantee erections or normal urinary control. Fertility-sparing surgery preserves reproductive organs in selected cancers, but cannot guarantee fertility or pregnancy.

Sometimes organ preservation uses radiotherapy and medicines instead of an operation. In selected rectal cancer pathways, a carefully assessed complete clinical response may lead to a structured “watch-and-wait” discussion. This means specialist surveillance with its own risks and responsibilities.

Ask what function is realistically expected with each option and what rehabilitation would involve. Early advice from a fertility specialist, physiotherapist, speech and swallowing therapist or stoma nurse can help you prepare and make choices.

Could reconstruction help with function or appearance?

If removing cancer leaves an area that needs repair, reconstructive surgery can rebuild or replace tissue. It may help restore swallowing, speech, movement, a route for food or urine, or body shape. A cosmetic outcome concerns appearance; a functional outcome concerns how the body works. Both can matter deeply and should be discussed alongside cancer control.

Cosmetic surgery mainly changes appearance. Reconstruction after cancer can improve appearance while also addressing a treatment-related defect or loss of function. Ask the team to explain the purpose of each proposed procedure and which parts of it are covered in the estimate or insurance authorisation.

Immediate, delayed and staged reconstruction

Immediate reconstruction takes place during the cancer operation. Delayed reconstruction happens later. Staged reconstruction uses more than one planned procedure. The choice depends on the cancer operation, likely radiotherapy or other treatment, general health and your preferences. Complications can affect recovery and the timing of further cancer treatment.

Grafts, flaps, implants and microsurgery

The choice depends on what needs repairing. A skin graft transfers skin and needs to develop a blood supply from the area where it is placed. A flap transfers tissue with its own blood supply; it may contain skin, fat, muscle or bone. A local or regional flap uses nearby tissue, while a pedicled flap stays connected to its original blood supply as it is moved.

A free flap comes from another part of the body. Small blood vessels are reconnected using microsurgery or microvascular reconstruction. The donor site, where the tissue comes from, also needs healing and may have scars, discomfort or functional effects.

An implant or prosthesis replaces or supports a body structure. Some are internal; others, such as an external breast form, are worn outside the body. Ask how the proposed repair would affect recovery, sensation and future procedures.

Breast reconstruction and oncoplastic surgery

Oncoplastic breast surgery combines cancer removal with reshaping. Reconstruction after mastectomy may use an implant, a temporary tissue expander that stretches the skin, or your own tissue, called autologous reconstruction. Examples include a deep inferior epigastric perforator (DIEP) flap using abdominal skin and fat, a transverse rectus abdominis myocutaneous (TRAM) flap that includes abdominal muscle, or a latissimus dorsi flap using tissue from the back.

Discuss likely shape, symmetry, sensation, scars, recovery, implant or flap complications and the possibility of revision surgery. Reconstruction cannot promise a breast that looks or feels exactly as it did before. Skin-sparing or nipple-sparing mastectomy is suitable only in selected circumstances. Aesthetic flat closure, choosing no reconstruction, or using an external prosthesis are also valid choices.

Reconstruction beyond the breast

Head-and-neck reconstruction may use soft tissue or bone to support chewing, swallowing, speech and appearance. Limb reconstruction may use replacement bone or an internal metal prosthesis. After bladder removal, a urinary diversion creates a new route for urine: options may include an ileal conduit with a urostomy bag or a neobladder made from bowel. A neobladder is not a normal bladder; emptying, continence and sometimes catheter use require teaching.

If reconstruction may be needed, ask about it before the cancer operation where possible. You can ask for a joint discussion with the cancer surgeon and reconstructive team. It is reasonable to prioritise comfort, function, appearance or avoiding additional operations in different ways.

What if I need a bowel join, stoma or feeding support?

Some operations change how food, stool, urine or air passes through the body. The team should explain any planned change and teach you how to manage it. An anastomosis is a surgical join, for example reconnecting bowel after a section is removed. A bypass creates a route around a blockage. A stoma brings an opening to the body surface so stool, urine or air can pass through it, depending on the operation.

  • A colostomy brings large bowel to the abdomen; an ileostomy brings small bowel to the abdomen. Stool collects in an appliance or bag.
  • A diverting or defunctioning stoma may protect a bowel join while it heals, or relieve an obstruction.
  • A urostomy diverts urine to an opening and bag.
  • A tracheostomy creates an opening into the windpipe to help breathing in particular circumstances.
  • A gastrostomy or jejunostomy can provide feeding access into the stomach or small bowel.

A stoma may be planned as temporary or permanent. “Temporary” describes the intention; whether and when it can be reversed depends on healing, subsequent treatment, fitness and the remaining anatomy. Ask about the possibility before surgery even if it seems unlikely.

A specialist nurse can explain appliances, skin care, supplies and everyday activities. Before going home, you and a caregiver, if you wish, should have practical teaching. Ask about output, hydration and when to call: unusually high ileostomy output, very little urine or difficulty keeping fluids down can need prompt attention.

Not every change described here will apply to you. Ask your surgeon to identify what is likely, what is only a possibility, and what support will be available if it happens.

For rectal cancer specifically, read about temporary and permanent stoma choices.

Choosing open, keyhole or robotic surgery

After discussing what the operation needs to achieve and how your body may be affected, you can compare how the surgeon would perform it. The surgical approach describes how the surgeon reaches the cancer. It is separate from the extent of the cancer operation. For example, the same organ resection may sometimes be performed through open, laparoscopic or robotic access.

Open surgery

The surgeon works through a larger incision, or cut. Open abdominal surgery is called a laparotomy; open chest surgery is a thoracotomy. Open access may be the safest or most appropriate choice for the cancer, previous operations, reconstruction or an emergency.

Minimally invasive or minimal access surgery

These terms often mean keyhole surgery, using small cuts, a camera and specialised instruments. Laparoscopic surgery uses this approach in the abdomen or pelvis. Thoracoscopic surgery uses it inside the chest; video-assisted thoracoscopic surgery is shortened to VATS.

In suitable operations, smaller cuts may reduce wound discomfort and help recovery. The internal operation can still be major. Risks such as bleeding, infection, injury to nearby structures or a leak from a bowel join remain possible.

Robot-assisted surgery

In robotic surgery, the surgeon controls instruments through a surgical system, usually from a console. The system can provide a magnified view and instruments with a wide range of movement. It does not independently decide what to remove or perform the operation without the surgeon.

A da Vinci system is one example of a robotic platform. Robot-assisted thoracic surgery is sometimes called RATS. The platform name does not establish that it is the right approach for your cancer. Robotic surgery cannot guarantee better cancer control, normal continence, preserved sexual function or freedom from complications.

Can keyhole surgery change to open surgery?

Yes. Conversion to open surgery may be needed because of bleeding, scar tissue, unexpected findings, difficulty seeing important structures or the need to complete the operation safely. This possibility should be discussed before consent. Conversion is not automatically a failure of treatment.

Endoscopic and transanal procedures

An endoscope is a thin instrument with a camera passed through a natural opening, such as the mouth, anus or urinary passage. Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) can remove selected very early cancers from the inner lining of an organ. The depth and laboratory features determine whether this is sufficient.

Transanal excision removes a selected rectal lesion through the anus. Techniques can include transanal endoscopic microsurgery (TEM). Local removal may not assess the surrounding lymph nodes, and additional treatment may be needed after the final pathology.

Laser surgery, cryosurgery using extreme cold, and other ablative treatments that destroy tissue have selected uses. Ablation is different from removing a specimen for full margin assessment. “Laser”, “robotic” or “keyhole” alone does not tell you whether a treatment is appropriate.

A useful question is: “For my particular operation, what difference would each approach make to cancer control, complications, function, recovery and cost?” The choice should reflect your circumstances and the team’s experience with that procedure.

Getting ready for surgery

Once you have agreed a plan, preparation turns that decision into practical steps. You are not expected to organise everything yourself: ask who will coordinate your tests, medicines, nutrition and support at home.

Prehabilitation means preparing physically and emotionally for treatment. The aim is to support your strength and recovery in the time available, without delaying necessary cancer treatment on your own.

Assessment and tests

A preoperative assessment reviews your medical conditions, functional ability, nutrition, medicines and previous operations or anaesthetics. Tests may include blood tests, an electrocardiogram (ECG) recording the heart rhythm, and other heart, lung or imaging tests when relevant. Not everyone needs the same tests. Frailty, day-to-day function and support needs matter alongside age.

Nutrition, activity and smoking

Tell the team about weight loss, reduced eating, swallowing difficulty or loss of strength. A dietitian can help with food, protein, supplements or feeding support according to your needs. Avoid starting a restrictive diet, fasting regimen or unprescribed supplements to “prepare” for surgery.

Ask which activity is safe for you, including walking, strength work or breathing exercises. Support with stopping smoking and reducing harmful alcohol use can be part of preparation. Tell the team about alcohol dependence so withdrawal can be managed safely. Sleep, anxiety and emotional support are also worth discussing.

Medicines and fasting instructions

Bring an up-to-date list of prescriptions, over-the-counter medicines, vitamins, herbal products and allergies. Include blood thinners, diabetes and weight-loss medicines, insulin and steroids. Ask for a written plan stating what to continue, pause and restart; do not make these changes yourself.

Follow the hospital’s exact instructions about when to stop food and drinks. Requirements can differ with the operation, anaesthetic and your health. Bowel preparation, special drinks or antibiotics are used only when prescribed. Let the team know if you develop a new illness or cannot follow the preparation instructions.

Planning for home

Arrange transport, help with meals and household tasks, time away from work, and care for children or other dependants. Raise stairs, mobility difficulties, living alone or financial worries before admission. You can use the Caregiver toolkit to organise practical support.

Before admission, keep the written operation and preparation plan somewhere you can easily find it, along with the hospital’s contact number. If anything is unclear, ask before changing medicines, food or drink.

Giving consent and the day of your operation

Consent is a conversation about the intended operation, expected benefit, important risks, alternatives and possible changes during surgery. Ask which organs or structures may be removed, whether a stoma or reconstruction may be needed, and what could lead the surgeon to stop or change the operation. You should have an opportunity to ask questions before agreeing.

An anaesthetist plans your anaesthesia and helps manage pain and body functions during surgery. General anaesthesia makes you unconscious; regional anaesthesia numbs a larger area, and local anaesthesia numbs a small area. Sedation helps you relax and may be combined with another method. The choice depends on the operation and your health.

The team confirms your identity, procedure, consent, allergies and relevant safety checks. An intravenous (IV) cannula provides access to a vein. During the operation, staff monitor functions such as breathing, heart activity and blood pressure. Ask about blood transfusion, blood-conservation measures and any personal preferences that could affect care.

Afterwards, you go to a recovery area, sometimes called the post-anaesthesia care unit (PACU). Some people need a high-dependency unit (HDU) or intensive care unit (ICU), either planned or because closer support is needed. A planned ICU stay does not itself mean something has gone wrong.

Recovery in hospital: comfort, movement and support

After surgery, the team helps you recover from the anaesthetic, stay comfortable and gradually return to eating and movement when safe. This is postoperative care, sometimes called post-op care. Your recovery depends on the operation, previous treatment, nutrition, fitness and any complications; it need not follow someone else’s timetable.

Enhanced Recovery After Surgery (ERAS)

ERAS is a coordinated approach combining preparation, anaesthesia, pain control, nutrition, movement and rehabilitation. Eating, drinking and walking begin when your team judges them safe. It is an individual recovery plan, rather than a promise of a fixed discharge day. After some operations, feeding or activity needs to progress more slowly.

Physiotherapy, occupational therapy, dietetic support, speech and swallowing therapy or stoma teaching may be part of care. Rehabilitation helps restore ability and confidence; it can continue after discharge.

Pain, nausea and movement

Pain control may combine tablets or IV medicines with a nerve block or epidural, which delivers pain medicine near spinal nerves. Patient-controlled analgesia (PCA) lets you give a controlled dose through a programmed pump. Only you should press its button; family or caregivers must not press it for you. Tell the team if pain prevents deep breathing, coughing, sleep or movement; you do not have to tolerate poorly controlled pain.

Anti-sickness treatment, breathing exercises and supported coughing may help recovery. Staff help you sit out of bed and walk when it is safe. Clot prevention may include movement, compression devices or prescribed anticoagulant medicines, chosen according to your bleeding and clotting risks.

Drains, catheters and feeding tubes

A drain removes fluid or air; a urinary catheter drains urine from the bladder. A nasogastric tube passes through the nose into the stomach for a particular feeding or drainage purpose. Some patients need other feeding tubes, a chest drain or temporary oxygen. Their use and removal depend on the operation and recovery.

Ask what milestones matter for your discharge—for example, manageable pain, safe movement, an appropriate feeding plan and confidence with any equipment. Going home is one stage of recovery; it does not mean that healing is complete.

Going home and returning to daily life

Before discharge, ask for a written plan and the treating hospital’s daytime and out-of-hours contact numbers. Use the surgical team’s urgent-care contact for a postoperative problem; an appointment or general enquiry service may not be able to provide urgent care.

  • Medicines: understand pain relief, constipation or nausea treatment, and when to restart your usual medicines. Continue clot-prevention injections or antibiotics only as prescribed.
  • Wound care: ask about dressings, showering, stitches, staples and signs of infection. Avoid applying powders, herbal products or creams unless the team recommends them.
  • Equipment: learn how to manage any drain, catheter, feeding tube or stoma, what to record, and whom to call about a problem.
  • Food and fluids: follow the plan for your operation. A dietitian can help if eating, weight or hydration is difficult.
  • Movement: build activity gradually within the instructions for lifting, exercise and wound protection. Balance rest with safe movement.
  • Appointments: confirm wound review, pathology discussion, rehabilitation and the next oncology appointment, including who will arrange them.

There is no single safe date for everyone to drive, return to work, lift weights, travel or resume sex. Ask about your operation, pain medicines, ability to perform an emergency stop and relevant insurance requirements before driving. Major surgery and long journeys can affect clot risk, so discuss travel plans with the team.

Fatigue, changes in sleep and emotions can continue after the wound looks healed. Scar appearance and numbness can change over time. Ask for help with body image, intimacy, anxiety, mood or a recovery that is slower than expected. Persistent or worsening symptoms deserve assessment.

Knowing which changes are expected—and which need help—can make going home less uncertain. Ask the team to go through the warning signs below and add any instructions specific to your operation.

When to seek help after surgery

You do not need to diagnose a complication yourself. Act on symptoms and the instructions from your surgical team. If you are unsure whether a change is expected, contact them; use emergency care for the severe symptoms below.

When to seek urgent medical care

Go to the nearest emergency department immediately for new chest pain, severe breathlessness, coughing blood, collapse, new severe confusion or uncontrolled bleeding. Do not wait for a routine appointment or a WhatsApp reply.

Contact your surgical team urgently for a temperature of 37.5°C (99.5°F) or higher, or the lower threshold in your discharge instructions; worsening or severe pain; a wound that becomes increasingly hot, swollen, opens or leaks pus; persistent vomiting; inability to drink; difficulty passing urine; or a new painful, swollen arm or leg. If the team is unavailable or you feel seriously unwell, seek urgent hospital care.

Severe abdominal pain, increasing abdominal swelling or feeling very unwell after bowel surgery can signal a serious problem, including a leak. A leak can sometimes occur without prominent pain. Follow any additional operation-specific instructions. Do not wait for a fever if you feel seriously unwell.

Understanding the risks your team discusses

Every operation has risks. Ask for the risks relevant to your procedure and health, including how complications are recognised and treated. Possible problems include bleeding, infection, blood clots, reactions to anaesthesia, injury to nearby structures and delayed wound healing. Major complications can require another procedure, readmission or intensive care, and some can be life-threatening.

If the team uses a technical word, ask what it means for your recovery. A haematoma is a collection of blood; a seroma is a collection of fluid near the operation site. Wound dehiscence means an incision partly or fully opens.

After an operation involving the bowel, an anastomotic leak means leakage from a surgical join. Ileus means the bowel temporarily slows or stops moving its contents; persistent vomiting or swelling needs assessment. A fistula is an abnormal connection between organs or to the skin.

Venous thromboembolism (VTE) means blood clots in veins. This includes deep vein thrombosis (DVT), often in a leg, and pulmonary embolism (PE), when a clot reaches the lungs.

Other effects depend on the operation: for example, chest complications, swallowing problems, altered bowel habit, continence or sexual changes, lymphoedema, persistent pain, or flap and implant problems. Discuss how these could affect the activities most important to you.

What the final report means for your next treatment

The operation and the final laboratory report answer related but different questions. Your surgeon can describe what happened during the procedure; the pathologist examines the removed tissue in detail. Waiting for the full report can be difficult, so agree when and how you will hear the results.

Histopathology is laboratory examination of tissue. The final surgical pathology report can describe the cancer type, size, grade, depth or extent, margins and lymph nodes. It may also record lymphovascular invasion, meaning cancer in small blood or lymph vessels, or perineural invasion, meaning cancer involving nerves. Their significance depends on the cancer.

Understanding stage and response to treatment

Grade describes how abnormal the cancer looks under the microscope. Stage describes its extent. A clinical stage uses information such as examination, scans and biopsy; a pathological stage uses information from the removed tissue. A stage after treatment before surgery may be written with a “yp” prefix. These findings can refine the treatment plan without meaning that the earlier assessment was careless.

Many solid cancers use TNM staging: T describes the main tumour, N describes regional lymph nodes, and M describes distant spread. The definitions differ by cancer, and some cancers use other systems. Removing a tumour or finding a positive node does not, on its own, tell you the complete stage.

A pathological complete response (pCR) means no residual cancer is found under the applicable cancer-specific definition in the tissue examined after treatment. It is different from a complete clinical response assessed without removing the tissue. Neither is an automatic guarantee against recurrence.

Margins and residual disease: R0, R1 and R2

R0 resection means no residual cancer is identified, with microscopically clear margins. R1 indicates microscopic residual cancer. R2 indicates visible residual cancer. These categories describe residual disease after treatment; they are not interchangeable with the cancer stage.

Clear margins or an R0 resection do not guarantee that cancer will never return. Further treatment may still be recommended for risks that surgery cannot fully address. If a margin is involved or close, options can include further excision, radiotherapy, drug treatment or observation in particular circumstances. Another operation is not automatic.

What do the lymph-node results mean?

The report may give the number examined and how many contained cancer. Micrometastases are small deposits; isolated tumour cells are an even smaller category in particular staging systems. Extranodal extension means cancer has grown beyond the node into nearby tissue. The significance differs by cancer. Negative nodes are reassuring information, but cannot prove that no cancer cells exist elsewhere.

Agreeing the next step

Ask when the complete report is expected, who will explain it, and whether further tests are pending. Specialist tests can take longer than the initial report. You can read how to understand a biopsy and pathology report alongside your own results.

Further treatment depends on the report, previous therapy, recovery, other health conditions and your preferences. Timing is individual: it should allow appropriate recovery while avoiding unnecessary delay. Follow-up or surveillance checks recovery and cancer status, supports long-term effects, and explains which symptoms to report between appointments.

Before that appointment ends, check that you know whether you need adjuvant treatment, when follow-up starts, and who to contact about recovery or new symptoms.

Questions and practical decisions to take to your team

You can use these questions at your first appointment or return to them as the plan develops. Choose the ones most relevant to you; there is no need to ask everything in one sitting.

Bring available pathology reports, scan reports and images, earlier treatment records, a medicine and allergy list, and your main questions. A family member or friend can join if you wish. Missing records should not stop you asking the team how to get started.

  1. What is the exact name and goal of my operation? What benefit is realistic for me?
  2. Why this operation, this amount of tissue removal and this treatment sequence? What are the alternatives?
  3. Which approach is recommended: open, laparoscopic, endoscopic or robotic? Could it change during surgery?
  4. Will you assess or remove lymph nodes? Would sentinel-node biopsy be appropriate?
  5. What margins are needed, and would frozen section help with any decision?
  6. Can an organ, nerves, sphincter or fertility be preserved safely? What function might change?
  7. Could I need a stoma, reconstruction, an implant or further operations?
  8. What are my important short- and long-term risks? What support would I need?
  9. Who provides the medicine, fasting, recovery and urgent-contact plans?
  10. When will we discuss final pathology, further treatment and follow-up?

Planning costs and insurance

Ask the hospital for an itemised estimate. Clarify surgeon and anaesthesia charges, operating theatre and robotic equipment, implants or reconstruction, pathology and frozen section, hospital or ICU stay, medicines, rehabilitation and follow-up. Ask what could fall outside a package, including complications or a longer admission.

Give the insurer the exact diagnosis, procedure and planned technique, including reconstruction if relevant. Confirm authorisation, sub-limits, room entitlement, co-payments and exclusions. Medical suitability and insurance coverage are separate questions. Read about treatment costs, insurance and practical support.

If you leave an appointment uncertain, ask the team to explain the next step again. A useful plan should make sense to you: its purpose, likely benefits and trade-offs, what happens next, and where to get help.

Surgery for symptom relief, cancer spread or inherited risk

The sections above describe the usual decisions and recovery discussions. The situations below have more specific goals and selection criteria. Read the part relevant to your diagnosis; these are not additional operations that everyone needs.

Can surgery help if cancer has spread?

Surgery may still help with a specific symptom or complication. In carefully selected people, removing limited sites of spread, called metastasectomy, may also form part of cancer treatment. Limited metastatic disease is sometimes called oligometastatic disease. Suitability depends on the cancer, all sites of disease, available treatments and overall fitness; finding one removable deposit does not automatically make surgery useful.

When the goal is relief: palliative surgery

Palliative surgery aims mainly to relieve symptoms or improve a particular function when removing all the cancer is not the goal. Examples include bypassing or relieving a bowel obstruction, creating a stoma, controlling bleeding, relieving pressure or stabilising a bone at risk of fracture. It can be considered alongside medicines, radiotherapy and supportive care.

The important question is whether the likely relief is worth the burden of the operation and recovery for you. A major operation may offer little benefit if recovery would take most of the time it could help. Sometimes an endoscopic stent, radiotherapy, drainage procedure, medicines or another less invasive approach may be preferable.

Ask what symptom the operation is intended to improve, how quickly relief is expected, how long it might last, and what happens if it does not help. Palliative care can support pain, symptoms and family needs while cancer treatment continues; it does not mean care has stopped.

When reducing abdominal cancer is part of the plan: CRS and HIPEC

Cytoreductive or debulking surgery reduces the amount of cancer in selected situations. How much the surgeon aims to remove, and whether this is likely to help, depend on the cancer and overall treatment plan.

Cytoreductive surgery (CRS) aims to remove visible cancer in selected settings. With cancer involving the abdominal lining, it may include a peritonectomy, removing affected peritoneum, and removal of involved organs or tissue. The operation can be extensive, with reconstruction or a stoma and a substantial recovery.

Hyperthermic intraperitoneal chemotherapy (HIPEC) circulates heated chemotherapy inside the abdomen during an operation, usually after cytoreduction. It is different from chemotherapy given into a vein. Whether it adds benefit depends on the original cancer, disease distribution, ability to remove disease and the particular treatment pathway. Not every cancer with peritoneal spread benefits from CRS or HIPEC.

The team may describe the peritoneal cancer index (PCI), a score recording disease distribution and amount, or a completeness of cytoreduction (CC) score, describing visible disease remaining after surgery. These scores answer different questions and need specialist interpretation.

Pressurised intraperitoneal aerosol chemotherapy (PIPAC) delivers chemotherapy as a pressurised spray inside the abdomen. It is different from HIPEC and remains a research approach in many settings. Ask what evidence supports it for your cancer and whether it is offered within a properly governed clinical study. A technology being available does not establish that it will help.

Before a cancer develops: prophylactic or risk-reducing surgery

Risk-reducing surgery removes tissue to lower the chance of a future cancer in a person with a sufficiently high risk. “Prophylactic” is another term you may hear. It is different from removing a cancer that is already present.

Examples include risk-reducing mastectomy in selected people at high inherited breast-cancer risk, removal of the fallopian tubes and ovaries in appropriate hereditary-risk situations, or bowel surgery for certain inherited polyposis conditions. A family history alone does not establish which operation, if any, is appropriate.

Discuss your personal risk with the relevant specialist and, where appropriate, a genetic counsellor. The decision includes the gene or condition involved, age, timing, screening alternatives, fertility, menopause, long-term health, reconstruction and personal preferences. Removing risk-bearing tissue reduces risk but does not make it zero. The possible benefits and irreversible effects need an individual discussion.

Removing both ovaries before natural menopause causes surgical menopause and affects fertility. Ask about the longer-term effects and their management before deciding.

Common questions about cancer surgery

These short answers revisit common worries. For the fuller explanation, use the sections above or ask your team how the answer applies to your operation.

Does every person with cancer need surgery?

No. The need depends on the cancer type, extent, available treatments, health and personal priorities. Some cancers are treated mainly with medicines or radiotherapy. Your team should explain why surgery is recommended, deferred or omitted.

Does a bigger or more radical operation give a better chance of cure?

Only when that extent is needed and supported by evidence for the cancer. Removing extra tissue can add harm without adding benefit. Ask what the recommended extent achieves and which functions it may affect.

If the tumour is technically resectable, does that mean I should have surgery?

No. The team must also establish that the proposed operation is likely to improve outcomes that matter to you compared with other options. Cancer biology and spread, expected benefit, function, risks and recovery all matter. An operation can be technically possible without being the best treatment.

Can surgery or a biopsy make cancer spread?

The risk of spread caused by standard biopsy or surgery is very low. Specialists choose the technique and tissue-handling precautions for the cancer concerned. Some tumours need carefully planned biopsy routes or removal methods; ask about your specific situation rather than delaying a recommended diagnosis or treatment.

Will I be cured if the surgeon removes everything visible?

Complete visible removal is important in many cancer operations, but microscopic cancer may remain or exist elsewhere. The final pathology and overall risk assessment guide whether additional treatment is needed. No operation can guarantee that cancer will never return.

Why have chemotherapy or radiotherapy first if the tumour can be removed?

For some cancers, treatment before surgery improves the overall plan by addressing microscopic disease, shrinking the tumour or making organ preservation more achievable. For others, surgery first is appropriate. Ask which evidence and goals apply to your diagnosis.

Is robotic surgery always better than laparoscopic or open surgery?

No. Suitability depends on the cancer operation needed, anatomy, previous treatment, the team’s experience and available resources. Discuss cancer control, complications, function, recovery and cost. The robot remains under the surgeon’s control.

Does keyhole surgery mean a minor operation?

No. Small skin cuts can be used for a major organ removal, lymph-node dissection or complex reconstruction. Preparation, internal healing and recovery needs still depend on the full operation.

Why might my surgeon stop after a diagnostic laparoscopy?

It may show spread or another finding that changes the balance of benefit and risk. Taking samples and recommending a different treatment can avoid a major operation that would not help. Ask beforehand what findings might change the plan.

Do clear scans mean I do not need lymph-node assessment?

Not necessarily. Scans cannot identify every microscopic deposit. Whether node assessment is useful, and which method is appropriate, depends on the cancer and the operation.

If a sentinel node contains cancer, must all the other nodes be removed?

Not always. The next step depends on the cancer, amount of nodal disease, other treatment and evidence for the particular situation. Options may include further surgery, radiotherapy, drug treatment or surveillance. A positive node alone does not mean distant spread.

Will a positive margin always mean another operation?

No. The team considers the site and meaning of the margin, cancer type, other pathology and treatments already given. Further surgery may help in some situations; other treatments or observation may be appropriate in others.

Why was frozen section not done, or why did the final report differ?

Frozen section answers selected questions and is not reliable or useful for every tissue or diagnosis. Permanent sections show more detail and may include extra sampling or specialist tests. Your surgeon and pathologist can explain what changed and whether it affects care.

Can I choose breast conservation or organ preservation?

You can ask whether it is safe and what treatment and follow-up it would involve. Suitability depends on the cancer, expected function and your priorities. The smallest operation is not always adequate, and retaining an organ does not guarantee normal function.

Is reconstruction only cosmetic, and do I have to have it?

Reconstruction may restore function, appearance or both. Some reconstruction is needed to close a defect or restore a route for food or urine; other choices are optional. Ask which applies. Where there is a choice, deciding against additional reconstruction is valid.

Can reconstruction happen during the same operation?

Sometimes. Immediate, delayed or staged reconstruction may be appropriate depending on the cancer, likely radiotherapy, health and preferences. Discuss it early so the cancer and reconstructive teams can plan together.

Will I need a permanent stoma?

That depends on the operation and remaining anatomy. Some stomas are planned as permanent; others are intended to be temporary. Reversal is a separate decision and cannot be guaranteed. Ask about the possibility and meet a stoma nurse before surgery where feasible.

Can surgery be useful when the cancer is stage IV?

Sometimes, for symptom relief or treatment of carefully selected limited sites of spread. Surgery is not automatically useful simply because a tumour can be removed. The team needs to consider all the cancer and the burden of recovery.

Does palliative surgery mean other treatment has stopped?

No. It describes the main purpose of that operation, usually symptom relief or better function. Medicines, radiotherapy and supportive care may continue as appropriate. Ask how the procedure fits your overall plan.

Does prophylactic surgery remove all future cancer risk?

No. Risk-reducing surgery can substantially lower a particular risk in selected people, but cannot eliminate it. Specialist and genetic counselling help compare the expected benefit with irreversible effects and screening alternatives.

Am I too old, or too weak, for cancer surgery?

Age alone does not decide. The team considers fitness, frailty, other illnesses, nutrition, likely recovery and your priorities. Some risks can be improved with preparation; for others, a different treatment may offer a better balance.

How painful will it be, and how long will I stay in hospital?

Both vary with the operation and your recovery. Ask about the pain plan, likely tubes or drains, expected milestones and possible HDU or ICU care. Tell the team if pain is preventing breathing, sleep or movement. Discharge does not mean complete recovery.

Can I go home with a drain, catheter or feeding tube?

Yes, when the team judges this safe and provides teaching, supplies, written instructions and follow-up. You should know what to monitor, who will remove or review the equipment and how to get help.

When can I work, drive, exercise or travel again?

Ask for advice based on your procedure, healing, medicines, job and journey. Recovery has no universal timetable. Build activity gradually, follow lifting restrictions and discuss long journeys and clot risk before booking travel.

Will surgery affect sex, fertility or my body image?

It can, depending on the organs, nerves and hormones involved. Raise concerns before treatment, including future pregnancy, erections, continence, menopause and visible changes. Fertility advice, rehabilitation, sexual-health support and counselling can help.

Why do I still need treatment or follow-up after an R0 operation?

R0 describes the absence of identified residual disease after the operation. It does not exclude all microscopic cells or future recurrence. Additional treatment may reduce risk in the relevant cancer, while follow-up also supports recovery and long-term effects.

Can the operation or discharge be delayed for safety?

Yes. Infection, blood-test abnormalities, poor nutrition, medicine issues or other problems may change the timing. Ask why, what is being done and when the plan will be reviewed. Do not stop prescribed medicines or change preparation to try to keep an appointment date.

Are all surgical techniques available at every hospital?

No. Specialist procedures, equipment and teams vary by hospital. Confirm where the proposed operation, reconstruction and postoperative care would take place, and whether the necessary expertise and support are available.

Understanding the name of your operation

An operation's name often describes the organ involved and how much is removed. These examples help you read a consent form or treatment plan; they are not a list of operations everyone needs. Ask your surgeon to explain your exact procedure, the lymph-node plan, any reconstruction and how daily life may change.

Word endings: -ectomy, -otomy, -ostomy and -plasty
-ectomy means surgical removal; -otomy means making an opening or incision; -ostomy means creating an opening, often to the body surface; -plasty means surgical repair or reshaping. The ending alone does not tell you the operation's size or purpose.
Wide local excision (WLE), lumpectomy and mastectomy
WLE removes a tumour with surrounding tissue. In breast surgery, lumpectomy or breast-conserving surgery removes the cancer while retaining the breast. Mastectomy usually means removing the whole breast; its full name identifies the type. Lymph-node surgery is discussed separately.
Lobectomy, segmentectomy and pneumonectomy
In lung surgery, a lobectomy removes one lung lobe; segmentectomy removes a smaller anatomical section within a lobe. Pneumonectomy removes one whole lung. The choice depends on cancer clearance and the lung function expected afterwards.
Gastrectomy and oesophagectomy
Gastrectomy removes part or all of the stomach. Oesophagectomy removes part or most of the food pipe. The team explains how the digestive tract will be reconnected and how eating, weight and nutrition may be affected.
Colectomy, TME, LAR and APR
Colectomy removes part or all of the colon. Total mesorectal excision (TME) removes the fatty tissue around the rectum containing its lymphatic structures. Low anterior resection (LAR) removes diseased rectum and reconnects the bowel when suitable. Abdominoperineal resection (APR) removes the rectum and anus, requiring a permanent colostomy.
Whipple procedure and hepatectomy
A Whipple procedure, or pancreaticoduodenectomy, removes the pancreatic head, duodenum, gallbladder and part of the bile duct, sometimes with part of the stomach. It includes digestive reconstruction. Hepatectomy means liver removal; a partial hepatectomy removes only the affected portion, preserving enough functioning liver.
Partial and radical nephrectomy
Partial nephrectomy, also called nephron-sparing surgery, removes the kidney tumour while retaining kidney tissue. Radical nephrectomy removes the whole kidney and surrounding tissue. Removal of nearby nodes or the adrenal gland depends on the findings; it is not automatic.
Prostatectomy, cystectomy and TURBT
Radical prostatectomy removes the prostate and seminal vesicles. Cystectomy removes part or all of the bladder. Transurethral resection of bladder tumour (TURBT) removes tumour through a scope passed into the urethra. These operations differ in their purpose and effects on urination, sexual function and fertility.
Hysterectomy and salpingo-oophorectomy
Hysterectomy removes the womb; a total hysterectomy also removes the cervix. Salpingo-oophorectomy removes a fallopian tube and ovary: unilateral means one side, bilateral means both. Ask exactly which organs are included and about fertility and menopause before surgery.
Neck dissection and craniotomy
Neck dissection removes selected groups of neck lymph nodes, sometimes with other tissue. Craniotomy opens a section of the skull so the neurosurgeon can reach the brain; the bone is usually replaced. Neither name alone describes how much cancer can safely be removed.

Words such as partial, total, radical and extended describe different extents of surgery. A more extensive operation is appropriate only when its expected benefit justifies its risks. Your cancer-specific guide explains the choices for that diagnosis.

Sources and further reading

Selected authoritative resources for the main topics in this guide. Cancer-specific advice should be discussed with your treating team.

Medically reviewed and approved by Dr (Prof) Vijay Agarwal

Professor and Lead Consultant – Medical Oncology

Review record updated: Medical Review Policy

WE ARE HERE TO HELP

Let’s take the next step together.

Talk to our cancer care team about an appointment, a second opinion or choosing a centre.

Scan to contact CTI on WhatsApp

Scan to WhatsApp

CallWhatsAppBook appointment

Translate this page

Choose a language. Google Translate opens in a new tab; this English page stays open.

ಕನ್ನಡKannadaहिन्दीHindiதமிழ்TamilతెలుగుTeluguമലയാളംMalayalamবাংলাBengaliमराठीMarathi

Automatic translations are not medically reviewed by CTI and may contain errors. See our translation disclaimer.